Albert B. Sabin

The Sabin Vaccine Institute is a leading non-profit organization dedicated to extending the full benefits of vaccines to all people, regardless of who they are or where they live. Founded in 1993 to continue the legacy of Dr. Albert Sabin, the developer of the oral polio vaccine, the institute focuses on developing new vaccines for neglected tropical diseases and emerging infectious threats. Their current clinical pipeline includes candidates for Marburg virus, Sudan virus, and hookworm, utilizing advanced viral vector and recombinant protein technologies. Sabin collaborates extensively with global health partners, governments, and academic institutions to advance vaccine research, advocacy, and distribution.